Bob Seevers, former FDA reviewer, provides regulatory expertise in working with FDA, submissions, large and small molecules, cold chain, Quality, training, and Due Diligence. Bob worked for a decade and a half in nuclear medicine, eight years at FDA as a chemistry reviewer and team leader in several divisions, sixteen years at Eli Lilly  in Regulatory and Quality, and has worked for four years as a consultant with Pearl Pathways. 

Contact Info:

Email: [email protected]

Phone: 317-417-4771